MTRC has released European reimbursement report for lithotripsy for kidney stones in 11 EU countries

Oct 2019

The report presents a summary of the reimbursement situation for lithotripsy for kidney stones in Europe.

The following types of procedure are considered: extracorporeal shock wave therapy; intracorporeal (endoscopic) lithotripsy with different type of energy used.

The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

The report was developed using an official reimbursement information. You can learn more and request sample pages at the report’s page.

It is possible to order analysis only for individual countries and add procedure volume data.

The latest related news

The 2022 list of medical technologies approved for innovation funding (NUB) released in Germany

Feb 2022

On January 28, 2022, the Institute for the Hospital Remuneration System (InEK) has published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2021. The medical technologies belonging to the cardiovascular, ENT, eHealth, gastrointestinal, neuromodulation, neurovascular, orthopedic, and other technology groups obtained positive status 1.

Evidence-based Interventions Programme List 3 will include 17 new interventions in England

Jan 2022

On January 20, 2022, the Academy of Medical Royal Colleges (AoMRC) launched a consultation on the latest set of guidance (List 3) of the Evidence-based Interventions (EBI) Programme. EBI program develops guidance sets (Lists) for tests, treatments, and procedures based on recommendations from the Expert Advisory Committee and NICE assessments. Proposed List 3 covers 17 interventions across a range of medical specialties, including cardiology, ophthalmology, urology, and others. The deadline for comments submission is March 31, 2022.

DRG tariff system guide and the DRG tariffs for 2022 published in Denmark

Dec 2021

In early December 2021, the Danish Health Authority (Sundhedsdatastyrelsen) has published DRG tariffs, as well as psychiatric and rehabilitation rates for 2022. Later on, in mid-December 2021, the DRG tariff system (Takstsystem) guide for 2022 was also published. Among other changes, seven new DRGs, specifically in ENT, endoscopy, obstetrics, and gynecology fields, were introduced.

Rapid HTAs of seventeen medical devices released in Tuscany

Dec 2021

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 20520 of November 22, 2021, Tuscany Regional Healthcare has published assessments of seventeen medical devices of various therapeutic areas, including devices belonging to neurology, as well as gastrointestinal, urology, cardiovascular, orthopedics, peripheral vascular, and other fields of care.

Seven technologies will be supported by the 2022/23 MedTech Funding Mandate in England

Dec 2021

In early December 2021, NHS Accelerated Access Collaborative announced seven technologies that will be covered by the MedTech Funding Mandate (MTFM) in 2022/23: four for benign prostatic hyperplasia treatment (UroLift, GreenLight XPS, Rezum, and PLASMA system), and three for improving the patient experience during procedures (XprESS multi-sinus dilation system, Thopaz+, and Spectra Optia). Four technologies included in 2021/22 (placental growth factor-based testing, SecurAcath, HeartFlow, and gammaCore) will continue to be supported.